FindTrial
Sign In

Treating osteosarcoma: developing a biobank and Wnt inhibition therapeutics

Treating osteosarcoma: developing a biobank and Wnt inhibition therapeutics

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800017855
Enrollment
Unknown
Registered
2018-08-17
Start date
2018-08-17
Completion date
Unknown
Last updated
2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteosarcoma

Interventions

Biobank:Patient derived organoid culture

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients diagnosed as osteosarcoma.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Viability;—

Countries

USA

Contacts

Public ContactHe Aina
aina.he@childrens.harvard.edu+86 18930172898

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026